Interferon-1beta (Betaseron, BAY86-5046)

DRUG2 trials

Sponsors

Bayer

Conditions

Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting

Unknown Phase

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

CompletedNCT00461396

BayerMultiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting

Start: 2007-05-31End: 2009-11-30Updated: 2011-04-08

Physical Disability in Patients Treated With Betaferon

CompletedNCT00873340

BayerMultiple Sclerosis

Start: 2007-10-31End: 2011-01-31Updated: 2014-06-26